Table 1.
Proteins reduced or increased in endometriosis versus controls
| Accession | Description | Gene | No. of samples in which the protein was detected in control group | No. of samples in which the protein was detected in control group | Abundance index in controls (average ± SD) (×106) | Abundance index in patients (average ± SD) (×106) | Previously associated with endometriosis |
|---|---|---|---|---|---|---|---|
| P01833 | Polymeric immunoglobulin receptor | PIGR | 10 | 10 | 23.18 ± 14.63 | 241.86 ± 135.40 | No |
| P19652 | Alpha-1-acid glycoprotein 2 | A1AG2 | 8 | 10 | 3.37 ± 3.07 | 29.62 ± 20.06 | Yes, in peritoneal fluid [71] |
| P23142 | Fibulin-1 | FBLN1 | 10 | 10 | 4.52 ± 5.09 | 13.44 ± 5.61 | Yes, in endometrium [72] |
| P01033 | Metalloproteinase inhibitor 1 | TIMP1 | 10 | 10 | 6.32 ± 5.64 | 38.98 ± 27.67 | Yes, in endometrium [24] |
| P80188 | Neutrophil gelatinase-associated lipocalin | NGAL | 10 | 10 | 8.72 ± 5.14 | 19.35 ± 9.40 | Yes, in urine [50] |
| P01024 | Complement C3 | CO3 | 8 | 10 | 2.03 ± 3.56 | 5.93 ± 2.37 | Yes, in peripheral blood [73] |
| P54108 | Cysteine-rich secretory protein 3 | CRIS3 | 10 | 6 | 3.11 ± 1.62 | 0.58 ± 0.11 | No |
| P04908 | Histone H2A type 1-B/E | H2A1B | 10 | 6 | 4.68 ± 3.22 | 1.04 ± 1.08 | No |
| P07476 | Involucrin | INVO | 8 | 6 | 2.18 ± 1.56 | 0.55 ± 0.88 | No |
| Q16777 | Histone H2A type 2-C | H2A2C | 10 | 4 | 4.66 ± 3.80 | 0.97 ± 1.84 | No |
| Q96KK5 | Histone H2A type 1-H | H2A1H | 10 | 4 | 4.66 ± 3.58 | 1.03 ± 0.77 | No |
| P04792 | Heat shock protein beta-1 | HSPB1 | 10 | 4 | 4.61 ± 0.97 | 1.15 ± 1.84 | No |
| P20160 | Azurocidin | CAP7 | 8 | 4 | 1.31 ± 0.97 | 0.38 ± 0.06 | No |
| P05109 | Protein S100-A8 | S10A8 | 10 | 10 | 32.12 ± 17.23 | 15.45 ± 12.06 | No |
| P04075 | Fructose-bisphosphate aldolase A | ALDOA | 10 | 4 | 2.94 ± 1.21 | 1.32 ± 0.14 | No |